Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE1185.50-8.2 (-0.69 %)
PREV CLOSE () 1193.70
OPEN PRICE () 1195.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3934
TODAY'S LOW / HIGH ()1183.00 1197.00
52 WK LOW / HIGH ()994.35 1364.95
NSE1186.30-8.8 (-0.74 %)
PREV CLOSE() 1195.10
OPEN PRICE () 1200.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1186.30 (35)
VOLUME 458919
TODAY'S LOW / HIGH() 1182.00 1200.20
52 WK LOW / HIGH ()1010 1356.2
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1986

Management Info :

Mangalam Ramasubramanian Kumar - Chairman K Nityananda Reddy - Managing Director

Registered Office :

Address : Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone : 040-23736370 / 23747340

Website : www.aurobindo.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
15Dec Aurobindo Pharma’s arm gets 3 observat
The United States Food and Drug Administration (USFDA) has inspected Aur..
02Dec Aurobindo Pharma informs about newspap
Aurobindo Pharma has enclosed the copies of notice published by the Comp..
27Nov Aurobindo Pharma informs about press r
Aurobindo Pharma has informed that it enclosed the copies of notice for..
06Nov Aurobindo Pharma reports marginal rise
Aurobindo Pharma has reported result for second quarter ended September..
30Oct Clarification With Reference To Move
Submission of clarification with reference to movement of volume.
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit5813.717467.9
Gross Profit 7552.8 23584.5
Operating Profit 8842.228856.9
Net Sales 27897.2109333
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 16500.00 (2.63%)
M.Cap ( in Cr)
21169.32
CORONA Remedies (BSE)
 1437.20 (35.33%)
M.Cap ( in Cr)
8789.93
Procter&Gamble Healt (BSE)
 5663.25 (1.51%)
M.Cap ( in Cr)
9400.65
Fredun Pharma (BSE)
 1660.40 (5.00%)
M.Cap ( in Cr)
783.98
RPG Life Sciences (BSE)
 2375.00 (2.90%)
M.Cap ( in Cr)
3928.02
Shareholding Pattern
PROMOTERS 51.82%
MUTUAL FUNDS/UTI 19.3%
NON-INSTITUTION 6.38%
FI/BANKS/INSURANCE 5.87%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85213.36-54.30 (-0.06%)
NIFTY26027.30-19.65 (-0.08%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI